Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)

This study is ongoing, but not recruiting participants.
Information provided by Zymenex A/S

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Metachromatic Leukodystrophy
2		Additional conditions recognized in this trial
			Leukodystrophy, Metachromatic
3		More general conditions related to this trial
			Brain Diseases
			Brain Diseases, Metabolic
			Brain Diseases, Metabolic, Inborn
			Central Nervous System Diseases
			Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			Demyelinating Diseases
			Genetic Diseases, Inborn
			Hereditary Central Nervous System Demyelinating Diseases
			Lipid Metabolism Disorders
			Lipid Metabolism, Inborn Errors
			Lipidoses
			Lysosomal Storage Diseases
			Lysosomal Storage Diseases, Nervous System
			Metabolic Diseases
			Metabolism, Inborn Errors
			Nervous System Diseases
			Nutritional and Metabolic Diseases
			Sphingolipidoses
			Sulfatidosis
4		Interventions listed in this trial
			Metazym
5		Sponsors listed in this trial
			Zymenex A/S